The human microbiome market will grow at a CAGR of 20.42% to reach US$2,383.317 million in 2030 from US$941.215 million in 2025.
Major factors driving the global human microbiome market growth are increasing instances of lifestyle diseases, diarrheal infections, predominant changes in the lifestyle of the global population, and an increase in the aged population and its applications in healthcare. Moreover, technological enhancements in biomedical sciences and growing research investment in technology and product sectors is also positively impacting the market growth positively. However, lack of awareness about the use and advantages of prebiotics and probiotics and government restrictions on their usage are major challenges for the market players.
The global human microbiome market report provides a detailed analysis of the industry landscape, offering strategic and executive-level insights supported by data-driven forecasts and analysis. This regularly updated report equips decision-makers with actionable intelligence on current market trends, emerging opportunities, and competitive dynamics. It explores consumer demand across various regions and product types, such as therapeutics, diagnostics, and probiotics, while also examining purchasing behaviours and key customer segments. Additionally, the report delves into technological advancements, key government policies, regulation.
Global Human Microbiome Market Segmentation by product:
The market analyzed by product into the following:
Global Human Microbiome Market Segmentation by disease:
The market analyzed by disease into the following:
Global Human Microbiome Market Segmentation by application:
The market analyzed by application into the following:
Global Human Microbiome Market Segmentation by regions:
The study also analysed the global human microbiome market into the following regions, with country level forecasts and analysis as below:
The global human microbiome market features key players such as Seres Therapeutics, Microbiome Therapeutics Innovation Group, Vedanta Biosciences Inc., Metabiomics, Ferring Pharmaceuticals, Finch Therapeutics, BiomeBank, Biohm Technologies, Resbiotic, Immuron Limited, Maat Pharma among others.
This report provides extensive coverage as explained in the points below:
How this report is helpful to you and reasons for purchase?
| Report Metric | Details |
|---|---|
| Study Period | 2021 to 2031 |
| Historical Data | 2021 to 2024 |
| Base Year | 2025 |
| Forecast Period | 2026 β 2031 |
| Report Metric | Details |
| Human Microbiome Market Size in 2025 | US$941.215 million |
| Human Microbiome Market Size in 2030 | US$2,383.317 million |
| Growth Rate | CAGR of 20.42% |
| Study Period | 2020 to 2030 |
| Historical Data | 2020 to 2023 |
| Base Year | 2024 |
| Forecast Period | 2025 – 2030 |
| Forecast Unit (Value) | USD Million |
| Segmentation |
|
| Geographical Segmentation | North America, South America, Europe, Middle East and Africa, Asia Pacific |
| List of Major Companies in the Human Microbiome Market |
|
| Customization Scope | Free report customization with purchase |